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1Introduction
Neisseria meningitidis is a prominent cause of bacterial 
meningitis and severe sepsis. The organism asymptomati-
cally colonizes the nasopharyngeal mucosa, especially in 
young adults. In susceptible individuals, hyper- invasive 
strains of meningococci may invade the nasopharyngeal 
submucosa and subsequently enter the bloodstream 
(Stephens 2009). Diverse bacterial factors, involved in 
adhesion, invasion, dissemination, and protection of the 
organism from the innate human immune system, are 
expressed by N. meningitidis. These include the polysac-
charide capsule, lipooligosaccharide, type IV pili, and a 
large number of outer membrane or secreted proteins 
such as Opa, Opc, fHbp, NspA, App, MspA, NalP, HrpA- 
HrpB, NhhA, NHBA, NadA, and the porin proteins, PorA 
and PorB (Virji 2009; Hill and Virji 2012; Pizza and 
Rappuoli 2015).
Moonlighting proteins are increasing recognized for their 
roles in bacterial pathogenesis (Henderson and Martin 
2011). By definition, moonlighting proteins perform two 
or more biochemical functions using a single polypeptide 
chain (Jeffery 1999). Commonly they are enzymatically 
active with cytoplasmic roles in glycolysis or other metabolic 
pathways, or have roles in protein synthesis (elongation 
factor Tu) or protein stabilization and folding (DnaK), but 
are also displayed on the bacterial surface where they per-
form functions unrelated to their cytoplasmic roles, often 
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Neisseria meningitidis is a leading cause of fatal sepsis and meningitis worldwide. 
As for commensal species of human neisseriae, N. meningitidis inhabits the 
human nasopharynx and asymptomatic colonization is ubiquitous. Only rarely 
does the organism invade and survive in the bloodstream leading to disease. 
Moonlighting proteins perform two or more autonomous, often dissimilar, func-
tions using a single polypeptide chain. They have been increasingly reported 
on the surface of both prokaryotic and eukaryotic organisms and shown to 
interact with a variety of host ligands. In some organisms moonlighting proteins 
perform virulence- related functions, and they may play a role in the pathogenesis 
of N. meningitidis. Fructose- 1,6- bisphosphate aldolase (FBA) was previously 
shown to be surface- exposed in meningococci and involved in adhesion to host 
cells. In this study, FBA was shown to be present on the surface of both patho-
genic and commensal neisseriae, and surface localization and anchoring was 
demonstrated to be independent of aldolase activity. Importantly, meningococcal 
FBA was found to bind to human glu- plasminogen in a dose- dependent man-
ner. Site- directed mutagenesis demonstrated that the C- terminal lysine residue 
of FBA was required for this interaction, whereas subterminal lysine residues 
were not involved.
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by interacting with specific host molecules (Wang et al. 
2013). In meningococci, several putative moonlighting pro-
teins have been described including enolase, peroxiredoxin, 
and DnaK (Knaust et al. 2007), GapA1 (Tunio et al. 2010a), 
and fructose- 1,6- bisphosphate aldolase (FBA) (Tunio et al. 
2010b). Plasminogen binding on the meningococcal cell 
surface was first described by Ullberg and colleagues (Ullberg 
et al. 1992), and is a widely recognized phenomenon in 
bacterial pathogens (Lähteenmäki et al. 2005; Sanderson- 
Smith et al. 2012). In meningococci, enolase, peroxiredoxin, 
and DnaK were previously shown to bind plasminogen 
on the bacterial surface (Knaust et al. 2007).
Plasminogen (plg) is a 92- kDa plasma glycoprotein pro-
enzyme; posttranslational processing results in several dif-
ferent forms, but the circulating mature form is known as 
glu- plasminogen (glu- plg) reflecting the presence of an 
N- terminal glutamic acid residue. Glu- plg is composed of 
a small N- terminal preactivation peptide, five homologous 
disulfide- bonded triple- loop kringle domains (K1- 5) and a 
serine protease (SP) domain (Law et al. 2012). Kringle 
domains 1–4 occur naturally as a 38- kDa fragment of 
plasminogen, which is known as angiostatin due to its 
inhibitory effect on angiogenesis (Abad et al. 2002). The 
last kringle domain (K5), together with the SP domain, is 
known as mini- plasminogen. Kringle domains contain mul-
tiple lysine- binding sites (LBS); intramolecular binding 
between lysine residues and the LBS maintains glu- plg in 
a closed, activation- resistant, conformation (Ponting et al. 
1992). Competitive binding with interaction partners such 
as fibrin and cell surface receptors, allows glu- plg to adopt 
an open conformation, exposing an activation loop to cleav-
age by activators, such as tissue- type plasminogen activator 
(tPA) or urokinase- type plasminogen activator (uPA), to 
form plasmin (Lijnen 2001). Plasmin is a broad- spectrum 
serine protease which plays an essential role in hemostasis 
by degrading fibrin clots (Lijnen 2001). In addition, plasmin 
also cleaves extracellular matrix proteins including fibronec-
tin, vitronectin, and laminin (Plow et al. 1995), and activates 
collagenases, matrix metalloproteinases and latent mac-
rophage elastase, resulting in the cleavage of elastin, collagen, 
and proteoglycans (Murphy et al. 1999). Plasmin was also 
recently shown to be a potent inhibitor of the complement 
components C3 and C5 (Barthel et al. 2012a).
Bacteria can interfere with and manipulate the plg sys-
tem by two general mechanisms: firstly by producing 
activators of plg (e.g., streptokinase produced by 
Streptococcus pyogenes) (McArthur et al. 2012) and secondly 
by immobilizing plg (either directly or indirectly) on the 
bacterial cell surface, which may then be activated to 
plasmin by activators (Sanderson- Smith et al. 2012). 
Examples of bacterial surface- localized plg receptors include 
streptococcal α- enolase (Pancholi and Fischetti 1998), 
Escherichia coli fimbriae (Kukkonen et al. 1998), 
Haemophilus influenzae aspartase (Sjöström et al. 1997), 
and protein E (Barthel et al. 2012b). Sequestered plg 
contributes to processes such as ECM degradation, fibrinol-
ysis, degradation of immune effectors and adherence, thus 
enhancing bacterial colonization of, and dissemination 
within, the host (Bhattacharya et al. 2012).
We previously reported that FBA is a nonessential, 
surface- localized protein in N. meningitidis, which belongs 
to the Class II subfamily of FBAs (Tunio et al. 2010b). 
Importantly, FBA is required for optimal association of 
meningococcal cells to human epithelial and endothelial 
cells (Tunio et al. 2010b). More recently, FBA of 
Mycobacterium tuberculosis was shown to be an essential 
enzyme and partly localized to the bacterial surface where 
it contributes to plg binding (de la Paz Santangelo et al. 
2011). In this report, we further examine the properties 
and role of FBA on the cell surface of neisseriae. We 
demonstrate that: FBA is present on the surface of 
pathogenic and nonpathogenic species of neisseriae; 
aldolase activity is not required for cell surface localiza-
tion or anchoring of FBA; and that FBA binds human 
plg, principally via the C- terminal lysine residue.
Experimental Procedures
Bacterial strains
Escherichia coli JM109 (Table S1) was used for the expression 
of 6 × histidine- tagged rFBA and derivatives. E. coli XL10- 
Gold ultracompetent cells were used as a host strain for the 
construction of mutagenic plasmids. E. coli strains were grown 
at 37°C in Lysogeny Broth (LB) broth or on LB agar sup-
plemented, where appropriate, with ampicillin (100 µg mL−1), 
kanamycin (30 µg mL−1) or erythromycin (200 µg mL−1). 
Strains of Neisseria (Table S1) were grown at 37°C in air 
plus 5% CO2 on chocolated horse blood agar (Oxoid), Brain 
Heart Infusion (BHI) agar or BHI broth supplemented with 
1% Vitox (Oxoid) and kanamycin (50 µg mL−1) or eryth-
romycin (5 µg mL−1) where appropriate.
DNA manipulation
Genomic DNA was extracted from N. meningitidis using 
the DNeasy Tissue kit (Qiagen, Manchester, UK). Plasmid 
DNA was prepared by using the QIAprep Spin kit (Qiagen). 
DNA was quantified using a NanoDrop 1000 
Spectrophotometer (NanoDrop Technologies, Wilmington, 
Delaware, USA). Restriction enzymes were purchased from 
New England Biolabs. All enzymatic reactions were carried 
out according to the manufacturer’s instructions. A Rapid 
DNA Ligation kit (Fermentas Life Sciences, Vilnius, 
Lithuania) was used for ligation reactions. DNA sequenc-
ing was carried out by Source Bioscience, UK.
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Construction of meningococcal cbbA 
mutants
N. meningitidis cbbA mutants were obtained by natural 
transformation and allelic exchange utilizing a previously 
described mutagenesis plasmid (pSAT- 4; Table S2) (Tunio 
et al. 2010b). Replacement of cbbA with a kanamycin 
resistance cassette in mutant strains was confirmed by 
PCR and the absence of FBA expression confirmed by 
immunoblot analysis.
SDS- PAGE and immunoblotting
Proteins were electrophoretically separated using 10% poly-
acrylamide gels (Mini- Protean III; Bio- Rad, Hemel Hempstead, 
UK) and were stained using SimplyBlue Safestain (Invitrogen, 
Waltham, Massachusetts, USA) or transferred to nitrocellulose 
membranes (Schleicher & Schuell) by using a Trans- Blot SD 
semidry transfer cell (Bio- Rad) according to the manufac-
turer’s recommendations. Membranes were probed with 
mouse antipentahistidine antibody (Qiagen) or rabbit anti- 
FBA primary antibody (αR- FBA) diluted 1:10,000 or 1:1000, 
respectively, in blocking buffer [5% (wt/vol) nonfat dry milk, 
0.1% (vol/vol) Tween 20 in 1 × phosphate- buffered saline 
(PBS)] and incubated for 2 h. After washing in PBS with 
0.1% Tween 20 (PBST), membranes were incubated for 2 h 
with 1:10,000- diluted goat anti- mouse (or anti- rabbit) IgG- 
alkaline phosphatase conjugate (Sigma-Aldrich, Gillingham, 
Dorset, UK). After washing with PBST, blots were developed 
using BCIP/NBT- Blue liquid substrate (Sigma-Aldrich).
Flow cytometry
Samples were prepared for flow cytometry as described 
previously (Tunio et al. 2010b). Briefly, N. meningitidis 
strains were grown to OD600 ~0.7, and 1 × 10
7 cfu aliquots 
were centrifuged at 5000g for 5 min and resuspended in 
0.2 mL filtered PBS. Cells were incubated for 2 h with 
αR- FBA (1:500 diluted in PBS containing 0.1% BSA, 0.1% 
sodium azide and 2% fetal calf serum) and untreated cells 
were used as a control. Cells were washed with PBS and 
incubated for 2 h in the dark with goat anti- rabbit IgG- 
Alexa Fluor488 conjugate (Invitrogen; diluted 1:50). Again, 
untreated cells were used as a control. Finally, the samples 
were washed in PBS before being resuspended in 1 mL of 
PBS containing 0.5% formaldehyde. Samples were analyzed 
for fluorescence using a BD FACSAria flow cytometer and 
BD FACS Diva software (BD Biosciences, Oxford, UK). 
Cells were detected using forward and side scatter dot plots 
and bacterial aggregates and cell debris were excluded by 
defining a gating region. A total of 20,000 events were 
analyzed for fluorescence signals. Subsequent data analysis 
was done using WinMDI 2.9 software (Mybiosoftware, Provo, 
Utah, USA). For determination of plasminogen binding by 
neisserial cells, the cells were incubated with glu- plasminogen 
(3 µg mL−1; Merck Millipore, Damstadt, Germany) for 1 h 
at 37°C. Cells were washed three times with PBS and in-
cubated with goat anti- plasminogen antibody (1:100). After 
washing, donkey anti- goat IgG- Alexa Fluor488 conjugate 
(1:50 diluted) was added, and after further washing, cells 
were fixed and analyzed as previously described.
Site- directed mutagenesis of FBA residue D83
A single- nucleotide mutation (A–C) at position 248 of 
cbbA was introduced into pSAT- 9 (Table S2; for expres-
sion of rFBAD83A in E. coli) and pSAT- 12 (Table S2; for 
the expression of FBAD83A in N. meningitidis) using the 
QuikChange Lightning site- directed mutagenesis kit (Agilent 
Technologies Santa Clara, California, USA). Reactions were 
undertaken following the manufacturer’s instructions and 
utilizing primers FBA_D83AF and FBA_D83AR (Table S3). 
The plasmid resulting from the mutagenesis of pSAT- 12 
(pFS- 5; Table S2), was used to transform MC58ΔcbbA by 
natural transformation, thus introducing a single chromo-
somal copy of the mutated cbbA allele (encoding FBAD83A) 
and the downstream erythromycin resistance cassette in 
the intergenic region between NMB0102 and NMB0103, 
generating MC58ΔcbbA cbbAEctD83A. Insertion of the mu-
tated cbbA gene and erythromycin resistance cassette at 
the ectopic site was confirmed by PCR analysis and se-
quencing. Immunoblot analysis confirmed expression of 
FBA in MC58ΔcbbA cbbAEctD83A at similar levels to wild- 
type MC58 or MC58ΔcbbA complemented with a wild- type 
copy of cbbA (MC58ΔcbbA cbbAEct).
Expression and purification of recombinant 
FBA
All rFBA derivatives were expressed and purified as previ-
ously described (Tunio et al. 2010b). Briefly, E. coli cell 
pellets were resuspended in 20 mL lysis buffer (50 mmol L−1 
NaH2PO4, 300 mmol L
−1 NaCl, 10 mmol L−1 imidazole; 
pH 7.4) followed by a 10 min cycle of 30 sec sonication 
and 30 sec off, on ice. The cell lysate was centrifuged 
(4000g for 10 min) and the cleared lysate was loaded onto 
a HisTrap FF column (GE Healthcare Lifesciences) prepacked 
with Ni Sepharose six Fast Flow (GE Healthcare Lifesciences, 
Little Chalfont, Buckinghamshire, UK) connected to a 
ÄKTAprime plus liquid chromatography system (GE 
Healthcare Lifesciences), equilibrated with 10 column vol-
umes of wash buffer (50 mmol L−1 NaH2PO4, 300 mmol L
−1 
NaCl, 15 mmol L−1 imidazole; pH 7.4). Proteins were eluted 
by step elution using elution buffer (50 mmol L−1 NaH2PO4, 
300 mmol L−1 NaCl, 300 mmol L−1 or 500 mmol L−1 
imidazole; pH 7.4). HiTrap column prepacked with 5 mL 
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of Sephadex G- 25 Superfine (GE Healthcare Lifesciences) 
equilibrated with 5 column volumes of phosphate- buffered 
saline (PBS) was used for buffer exchange. Eluted fractions 
were collected in 50% glycerol. Chromatography was ana-
lyzed using Prime view 5.0 software (Amersham Biosciences, 
Little Chalfont, Buckinghamshire, UK). Purified elutes were 
concentrated using Vivaspin sample concentrators (Sartorius, 
Epsom, Surrey, UK; 10,000 MWCO). The kinetic analysis 
of fructose bisphosphate aldolase activity of rFBA and rF-
BAD83A was done using a previously described methodology 
(Tunio et al. 2010b).
Association assays
Association assays were performed essentially as previously 
described (Oldfield et al. 2007). Briefly, human brain mi-
crovascular endothelial (HBME) cells were grown to con-
fluence in Dulbecco’s Modified Eagle’s Medium (DMEM) 
supplemented with 10% heat- inactivated fetal calf serum 
(FCS; Invitrogen) and 2% antibiotic antimycotic solution 
(Invitrogen) in 24- well tissue culture plates (Costar, Sigma-
Aldrich) at 37°C in an atmosphere of 5% CO2. Prior to 
all experiments, monolayers were transferred to DMEM 
supplemented with 2% FCS. Meningococci were cultured 
for 2 h, and monolayers were infected with 1 × 107 cfu 
of meningococci and cultured for 2 h in 5% CO2 at 
37°C. Monolayers were washed four times with PBS and 
then disrupted and homogenized in 1 mL 0.1% saponin 
in PBS. Meningococci were enumerated by serial dilution 
of the homogenized suspensions and subsequent deter-
mination of colony- forming units by plating 50 µL aliquots 
from appropriate dilutions of the lysates on agar. All as-
says were repeated at least three times. Statistical signifi-
cance was measured using the two- tailed Student’s t- test. 
P value of ≤0.05 was considered significant.
ELISA
Microplate wells (Nunc 96- well plates, PolySorp) were coated 
with 100 µL volumes of 0.5 or 5 µg mL−1 glu- plg (from 
human plasma; Calbiochem), laminin (human placenta; 
Merck Millipore), fibronectin (human plasma; Sigma) or 
collagen I (human placenta; Corning) in 0.2 µm- filtered 
sodium carbonate buffer (142 mmol L−1 NaHCO3, 
8 mmol L−1 Na2SO3, pH 9.0) and incubated for 1 h. After 
washing five times with PBS- Tween (0.05%; PBST), wells 
were blocked with 100 µL of 0.2 µm- filtered 1% BSA in 
PBS for 1 h. After removal of the blocking solution, 100 µL 
of 5 µg mL−1 rFBA in 1% BSA/PBS was added and incu-
bated for 1 h. Following vigorous washing with PBST, 100 µL 
of mouse antipentahistidine antibody (Qiagen; diluted 1:2000 
in 1% BSA/PBS) was added for incubation for 1 h. Plates 
were again vigorously washed, before the addition of 100 µL 
goat anti- mouse IgG- horse radish peroxidase conjugate 
(Sigma-Aldrich; diluted 1:10,000 in 1% BSA/PBS), was added 
and incubated for 1 h. Plates were again vigorously washed, 
and the color was developed by adding 100 µL ABTS sub-
strate (Roche Applied Science, Burgess Hill, West Sussex, 
UK), and absorbance at 405 nm was measured using a 
Biotek EL800 spectrophotometer. Values shown are minus 
the values obtained from control wells coated with 1% BSA.
Alternatively, binding assays were undertaken as above, 
but using rFBA or its derivatives (10 µg mL−1) as the 
immobilized ligand to capture glu- plg (10 µg mL−1). Bound 
glu- plg was detected using goat anti- human plg (1:20,000; 
Rockland Immunochemicals, Pottstown, Pennsylvannia, 
USA) and donkey anti- goat IgG- alkaline phosphatase con-
jugate (1:5,000; Promega Southampton, Hampshire, UK). 
After washing, 200 µL of phosphatase substrate (Sigma), 
dissolved in buffer containing 0.1 mol L−1 glycine, 
1 mmol L−1 ZnCl2 and 1 mmol L
−1 MgCl2, pH 10.4, 
was added into each well and readings taken. The lysine 
analog, ε- aminocaproic acid (EACA; 5 mmol L−1) (Sigma-
Aldrich) was utilized for inhibition studies.
Cloning of truncated rFBA (tr- rFBA) and 
mutagenesis of C- terminal lysine residues
A 372 bp fragment of cbbA encoding the C- terminal 123 
amino acids was amplified from MC58 meningococcal DNA 
using the primers CterFBAF1 and CterFBAR1 (Table S3). 
The amplified fragment and pQE- 30 (Table S2) were di-
gested using BamHI according to the manufacturer’s in-
structions and ligated to form pFS- 7 encoding  N- terminally 
histidine tagged tr- rFBA. The FBA lysine residues (339K, 
346K, and 354K) were replaced by alanine residues using 
the QuikChange Lightning site- directed mutagenesis kit 
(Agilent Technologies) following the manufacturer’s instruc-
tions, yielding pFS- 71, pFS- 72, and pFS- 73, respectively 
(Table S2). Primers utilized are given in Table S3.
Results
FBA is present on the surface of N. 
gonorrhoeae and commensal neisseriae
We previously showed that FBA is expressed by a diverse 
collection of meningococcal isolates and by strains of 
N. gonorrhoeae, N. lactamica, and N. polysaccharea; flow 
cytometry confirmed the presence of FBA on the surface 
of the meningococcal serogroup B (MenB) strain MC58 
(Tunio et al. 2010b). Here, N. gonorrhoeae FA1090, N. 
lactamica ATCC 23970, and a clinical isolate of N. poly-
saccharea were subjected to flow cytometry analysis to 
detect surface- localized FBA. All three strains, when 
treated with both primary and secondary antibody, 
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demonstrated a clear shift in fluorescence signal indicat-
ing FBA surface localization (Fig. 1A). We also examined 
FBA surface localization in six additional meningococcal 
strains: two MenB; two serogroup C (MenC); one se-
rogroup X (MenX); and one serogroup Z (MenZ). Surface 
exposure of FBA was demonstrated in all strains exam-
ined (Fig. 1B). No shift in fluorescence signal was ob-
served following inactivation of the gene encoding FBA 
(cbbA) in the MenB and MenC isolates, confirming 
antibody specificity (Fig. 1C). Interestingly, reduced levels 
of fluorescently labeled bacteria were observed for the 
wild- type MenC strains (41.9% for Z4181; 48% for 8013, 
respectively) compared to the other meningococcal strains 
(Fig. 1B; all ≥77%). Taken together, our data suggest 
that FBA is commonly present on the cell surface of 
meningococcal strains and also in other neisseriae  species, 
including commensals.
FBA surface localization and moonlighting 
functions are not dependent on aldolase 
activity
Mutation of a specific aspartate residue (109D) in the cofactor- 
binding site of E. coli class II FBA abolishes aldolase activity 
(Plater et al. 1999). We replaced the corresponding residue 
(83D) in recombinant meningococcal FBA (rFBA) with ala-
nine. A coupled enzymic assay, which we previously used 
to estimate the kinetic parameters of rFBA for cleavage of 
fructose bisphosphate (FBP) (Tunio et al. 2010b), was used 
to confirm that purified rFBAD83A exhibited no detectable 
aldolase activity (data not shown). We next introduced a 
mutated cbbA allele encoding FBAD83A into N. meningitidis 
to investigate the effect of abolishing aldolase activity on 
FBA surface localization and moonlighting functions. To 
achieve this, site- directed mutagenesis was used to alter cbbA 
Figure 1. Flow cytometric analysis of Fructose- 1,6- bisphosphate aldolase (FBA) surface localization in neisseriae. Presence of FBA on the cell surface 
was detected by anti- FBA antiserum and anti- rabbit IgG- Alexa Fluor488. Fluorescence is displayed as a histogram: area enclosed by the dashed line 
indicates bacteria treated with primary antibody only; area shaded in gray indicates bacteria treated with secondary only; area enclosed by the solid 
line indicates bacteria treated with both antibodies. (A). FBA detected on the surface of N. gonorrhoeae, N. lactamica, and N. polysaccharea. (B). The 
presence of FBA confirmed on the surface of six wild- type N. meningitidis strains (serogroups in parentheses). (C). Detection of surface- localized FBA 
was abolished in N. meningitidis cbbA mutant derivatives.
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harbored by pSAT- 12, previously used to insert a wild- type 
copy of cbbA into MC58ΔcbbA at an ectopic site (Tunio 
et al. 2010b), to create pFS- 5. Natural transformation and 
allelic exchange of MC58ΔcbbA utilizing pFS- 5 yielded 
MC58ΔcbbA cbbAEctD83A. N. meningitidis MC58 wild- type, 
MC58ΔcbbA and MC58ΔcbbA complemented with either 
wild- type (MC58ΔcbbA cbbAEct) or mutated (MC58ΔcbbA 
cbbAEctD83A) cbbA alleles were then subjected to flow cy-
tometry analysis. As expected, wild- type MC58 and 
MC58ΔcbbA cbbAEct cells, treated with both primary and 
secondary antibody, demonstrated a shift in fluorescence 
signal; no corresponding shift signal was observed for 
MC58ΔcbbA confirming the absence of FBA on the surface 
of these cells. MC58ΔcbbA cbbAEctD83A cells showed clear 
evidence of surface- localized FBA confirming that aldolase 
activity is not required for surface localization (Fig. 2).
The ability of these same meningococcal strains to associ-
ate with human brain microvascular endothelial cells was 
then examined. These experiments showed no statistically 
significant differences between MC58ΔcbbA cbbAEct or 
MC58ΔcbbA cbbAEctD83A compared to wild- type (Fig. 3). In 
contrast, MC58ΔcbbA showed significantly reduced associa-
tion with HBME cells in line with previous results (Tunio 
et al. 2010b). Taken together, our data suggest that the aldolase 
activity of meningococcal FBA is not required for outer 
membrane targeting, surface localization or anchoring of FBA 
on the meningococcal surface, nor is it required for optimal 
association of N. meningitidis with human endothelial cells.
Terminal lysine- dependent plasminogen 
binding by meningococcal FBA
Bacterial moonlighting proteins have been shown to bind 
a variety of host proteins (Henderson et al., 2011). We 
screened the ability of rFBA to bind to glu- plg, fibronec-
tin, laminin, and collagen; rFBA bound significantly to 
each of these substrates in a dose- dependent manner 
but binding to glu- plg occurred at much higher levels 
than to the other proteins (Fig. 4A). Binding to glu- plg 
could be inhibited by the lysine analog, ε- aminocaproic 
acid (EACA), suggesting the involvement of one or more 
lysine residues (Fig. 4B); no significant difference in glu- 
plg binding was apparent in assays utilizing rFBAD83A 
confirming that aldolase activity was not required for 
the interaction with glu- plg (Fig. 4B). Glu- plg was also 
shown to bind to a truncated derivative of rFBA con-
taining the C- terminal 123 amino acids of rFBA (tr- rFBA; 
Figure 2. Aldolase activity is not required for surface localization or anchoring of meningococcal Fructose- 1,6- bisphosphate aldolase (FBA). FBA 
lacking aldolase activity (FBAD83A) could be detected on the cell surface of MC58ΔcbbA cbbAEctD83A cells. Fluorescence is displayed as a histogram: 
area enclosed by the dashed line indicates bacteria treated with primary antibody only; area shaded in gray indicates bacteria treated with secondary 
only; area enclosed by the solid line indicates bacteria treated with both antibodies.
Figure 3. Complementation with either wild- type cbbA or cbbAD83A 
restores the ability of MC58ΔcbbA cells to associate with human brain 
microvascular endothelial cells. Values shown are means from five 
independent experiments carried out in triplicate wells. Error bars 
indicate SE. * denotes P <0.05 (Student’s t- test).
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Fig. 5). Given the likely involvement of lysine residues 
in the interaction, subterminal (339K and 346K), and 
terminal (354K) lysine residues were replaced with alanine 
in tr- rFBA using site- directed mutagenesis and the effects 
on glu- plg binding examined. Only the tr- rFBAK354A 
derivative exhibited a significantly reduced ability to bind 
glu- plg confirming a critical role for the terminal lysine 
residue of meningococcal FBA in plasminogen binding 
(Fig. 5).
Plasminogen binds to the surface of N. 
gonorrhoeae and commensal neisseriae
Glu- plg was shown to bind equally to the surface of wild- 
type MC58 and MC58ΔcbbA cells (94.6% for MC58; 92.5% 
for MC58ΔcbbA, respectively), suggesting considerable 
redundancy in plg binding to the bacterial surface (Fig. 6A). 
Glu- plg was also shown to bind to the surface of N. 
gonorrhoeae FA1090, N. lactamica ATCC 23970 and a 
clinical isolate of N. polysaccharea (Fig. 6B; all ≥90%).), 
suggesting that the cell surface binding of plg is a gen-
eralized phenomenon among neisserial species.
Discussion
We previously reported that FBA, a highly conserved class 
IIB aldolase, is localized to the outer membrane of N. 
meningitidis and is surface accessible to anti- FBA antibod-
ies (Tunio et al. 2010b). Furthermore, an FBA- deficient 
mutant showed reduced adherence to human epithelial 
and endothelial cells. One question that arises from these 
observations is whether the enzymatic activity of the pro-
tein is required for any aspect of the moonlighting process. 
More specifically, is aldolase activity a prerequisite for 
surface localization, surface anchoring or the function(s) 
of FBA on the bacterial surface? In an attempt to address 
these questions, recombinant wild- type and mutant de-
rivatives of rFBA were expressed and purified under non-
denaturing conditions and their respective aldolase activity 
determined. Mutation of the conserved aspartic acid residue 
in the predicted cation- binding site abolished the aldolase 
activity of rFBA. This result is in agreement with similar 
studies on the aldolase of E. coli which showed that the 
conserved aspartic acid residue is required for polarization 
of the carbonyl group of glyceraldehyde 3- phosphate dur-
ing catalysis (Plater et al. 1999). We introduced ectopic 
copies of either an intact cbbA gene or a derivative 
Figure 4. Meningococcal Fructose- 1,6- bisphosphate aldolase (FBA) is a 
plasminogen- binding protein. (A). rFBA exhibits significantly higher 
levels of binding to immobilized glu- plg than to laminin, fibronectin, or 
collagen. Means are from three independent experiments carried out in 
triplicate wells. rFBA used at 5 µg mL−1; solid- phase ligands at 0.5 or 
5 µg mL−1. Error bars indicate SE. * denotes P value <0.05 (Student’s 
t- test) compared to binding of rFBA to glu- plg (5 µg mL−1). (B). Binding 
of glu- plg to immobilized rFBA is inhibited by ε- aminocaproic acid 
(5  mmol L−1; EACA) suggesting the involvement of FBA lysine residues 
in the interaction. FBAD83A retains glu- plg binding activity, confirming 
that aldolase activity is not required for binding. Means are from three 
independent experiments carried out in triplicate wells. Error bars 
indicate SE. * denotes P value <0.05 (Student’s t- test) compared to 
binding in the absence of EACA.
Figure 5. Fructose- 1,6- bisphosphate aldolase (FBA) interacts with 
plasminogen via its terminal lysine residue (354K). Replacement of FBA 
residue 354K (tr- rFBAK354A), but not residues 339K (tr- rFBAK339A) or 346K 
(tr- rFBAK346A), leads to a significantly reduced ability to bind glu- plg. 
Values shown are means from three independent experiments carried 
out in triplicate wells. Error bars indicate SE. * denotes P value <0.05 
(Student’s t- test) compared to binding of glu- plg to tr- rFBA in the 
absence of EACA.
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harboring the mutation identified above into a cbbA null 
mutant strain of N. meningitidis. Proteins expressed from 
either gene were detected on the meningococcal surface 
indicating that aldolase activity is not required for trans-
portation of FBA to the surface of meningococcal cells 
or its stable anchoring on the cell surface.
Fructose- 1,6- bisphosphate aldolase expression is highly 
conserved in the family neisseriae; the protein being 
expressed by both pathogenic and nonpathogenic species 
(Tunio et al. 2010b). However, it remained to be deter-
mined whether FBA was localized to the surface in different 
strains of the meningococcus or other species of Neisseria. 
Our data suggest that the surface localization of FBA is 
likely to be ubiquitous among neisseriae. Interestingly, 
reduced fluorescence intensity was seen for two MenC 
strains compared to MenB, MenX, and MenZ strains. 
Analysis of additional strains will be required to determine 
whether this is a generalized phenomenon for MenC strains 
due to the nature of the polysaccharide capsule or results 
from differences in the level of capsular expression in these 
strains. Significantly, the presence of FBA on the surface 
of nonpathogenic commensal species of neisseriae suggests 
that the function of surface FBA might be of particular 
importance for the colonization of host epithelial cells. In 
Streptococcus pneumoniae, FBA functions as an epithelial 
cell adhesion and the host cell ligand was putatively identi-
fied as Flamingo cadherin receptor (Blau et al. 2007). 
Whether meningococcal FBA can also interact with this 
receptor will require further work.
Fructose- 1,6- bisphosphate aldolase has also been found 
on the surface of M. tuberculosis, where it binds plg and, 
after conversion of plg to plasmin, protects the latter from 
the regulatory effect of α2–antiplasmin (de la Paz Santangelo 
et al. 2011). The presence of plg- binding proteins, identi-
fied as enolase, DnaK, and peroxiredoxin on the surface 
of N. meningitidis has previously been reported (Knaust 
et al. 2007). Knaust et al. also noted the presence of addi-
tional, but unidentified, plg- binding proteins in the menin-
gococcus. Although FBA was not identified in that study, 
one of the unidentified plg- binding proteins had an apparent 
molecular weight of ca. 35- kDa, consistent with the pre-
dicted molecular weight of 38 kDa for FBA (Knaust et al. 
2007). Based on this report, and the fact that FBAs from 
a diverse range of pathogens including Candida albicans 
(Crowe et al. 2003), Cryptococcus neoformans (Stie et al. 
2009), M. tuberculosis (de la Paz Santangelo et al. 2011) 
Figure 6. Flow cytometric analysis demonstrating the binding of plasminogen to the surface of neisserial cells. Binding of glu- plg was detected by 
goat anti- plasminogen antibody and donkey anti- goat IgG- Alexa Fluor488. Fluorescence is displayed as a histogram: area enclosed by the dashed line 
indicates bacteria treated with primary antibody only; area shaded in gray indicates bacteria treated with secondary only; area enclosed by the solid 
line indicates bacteria treated with both antibodies.(A). Glu- plg binds equally to the surface of wild- type MC58 and MC58ΔcbbA cells. (B). Glu- plg 
binds to the surface of N. gonorrhoeae FA1090, N. lactamica ATCC 23970 and a clinical isolate of N. polysaccharea.
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and most recently Paracoccidioides (Chaves et al. 2015) have 
previously been shown to bind plg, we hypothesized that 
meningococcal FBA would also bind human plg. Our data 
confirm that meningococcal FBA binds plg in a dose- 
dependent manner, but only very low levels of binding to 
fibronectin, laminin, or collagen were observed. Further 
work would be required to determine whether meningo-
coccal FBA binds to additional host molecules.
We examined the binding of plg to wild- type N. men-
ingitidis MC58 and the cbbA null mutant. Wild- type and 
cbbA null mutant cells were able to bind plg at a similar 
level, indicating that, as expected, there is significant 
redundancy in surface binding of plg. Knaust et al. simi-
larly reported that deletion of peroxiredoxin did not have 
a detectable effect on surface plg binding. In the same 
study, despite several attempts, enolase or DnaK null 
mutant strains could not be generated, suggesting that 
these proteins are essential for cell viability, in addition 
to their moonlighting role on the cell surface. Furthermore, 
due to the high concentration of plg in human serum, 
all plg receptors on meningococcal cells are likely to be 
saturated. Consequently, the number of surface- exposed 
receptors, and their available binding epitope(s), is impor-
tant for this interaction, while the binding affinity is likely 
to be less important (Knaust et al. 2007).
As previously reported (Ullberg et al. 1992), we con-
firmed that N. gonorrhoeae can also bind plg, and for 
the first time demonstrated plg binding by the commensal 
species, N. lactamica, and N. polysaccharea. The occurrence 
of anchorless glycolytic enzymes on the surface of patho-
genic bacterial species and their interaction with plg and 
other human proteins is well established, but only recently 
has it become evident that similar strategies are adopted 
by commensal species. For example, enolase was reported 
as a surface receptor for plg in four Bifidobacterium spp., 
(Candela et al. 2009) and Lactobacillus plantarum enolase 
binds both fibronectin and plg (Vastano et al. 2013). 
Binding of plg may aid the survival of neisseriae on epi-
thelial surfaces and potentially enhance the virulence of 
N. meningitidis. Once plg is activated to plasmin, cells 
gain an enhanced capability to degrade fibrin clots, extra-
cellular matrix proteins or components of the innate 
immune system (Lähteenmäki et al. 2001). However, 
Sijbrandi et al. found that Pbp, a protein exposed on the 
surface of Bacteroides fragilis, can bind plg which is not 
then converted to plasmin, suggesting that sequestering 
plg on the bacterial surface may have other advantages 
(Sijbrandi et al. 2008). Similarly, triosephosphate isomerase 
(TPI) on the cell surface of Staphylococcus aureus decreases 
activation of plg bound by enolase (Furuya and Ikeda 
2011). Future work will examine whether plg bound by 
FBA is activated to plasmin or is retained on the bacterial 
surface in the inactive precursor form.
Having shown that meningococcal FBA is able to bind 
plg, we investigated which amino acid residues in FBA 
were required for optimal interaction. The binding we 
observed was sensitive to the lysine analog EACA, suggest-
ing that certain lysine residues in FBA were responsible 
for the interaction. Knaust et al. reported that internal 
lysine residues (rather than a terminal lysine) were impor-
tant for plg binding by enolase, DnaK, and peroxiredoxin 
(Knaust et al. 2007). Conversely, our site- directed mutagen-
esis approach demonstrated that the terminal lysine of FBA 
was primarily responsible for plg binding. Importantly, 
replacement of the terminal lysine with alanine did not 
completely abolish binding and the residual binding was 
still abolished in the presence of EACA, suggesting that 
other lysine residues within FBA may contribute to the 
interaction with plg. Mutation in the cation- binding site 
did not affect binding confirming that aldolase activity is 
not required for the plg- binding activity.
The neisseriae are, to date, the only Gram- negative 
bacteria in which surface- localized FBA has been described. 
However, FBA orthologs are present in other pathogenic 
Gram- negative bacterial species including, for example, 
Pseudomonas aeruginosa and Acinetobacter baumanii. 
Interestingly, Flores- Ramirez et al. recently reported the 
presence of FBA in the cell wall fraction of Coxiella bur-
netii, suggesting the possibility that translocation of FBA 
to the Gram- negative cell envelope might be a more 
generalized phenomenon (Flores- Ramirez et al. 2014). 
Finally, the presence of class II FBAs in many pathogens 
(and the absence of a structurally or antigenically similar 
protein in humans) makes FBA a potential target for 
antimicrobial therapy (Daher et al. 2010) and a possible 
vaccine candidate.
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